Cita APA (7a ed.)
Zang, Y., Guo, B., Qiu, Y., Liu, H., Opyrchal, M., & Lu, X. (2024). Adaptive phase I–II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies. Clinical Trials, 21(3), 298-308.
Cita Chicago Style (17a ed.)
Zang, Yong, Beibei Guo, Yingjie Qiu, Hao Liu, Mateusz Opyrchal, y Xiongbin Lu. "Adaptive Phase I–II Clinical Trial Designs Identifying Optimal Biological Doses for Targeted Agents and Immunotherapies." Clinical Trials 21, no. 3 (2024): 298-308.
Cita MLA (9a ed.)
Zang, Yong, et al. "Adaptive Phase I–II Clinical Trial Designs Identifying Optimal Biological Doses for Targeted Agents and Immunotherapies." Clinical Trials, vol. 21, no. 3, 2024, pp. 298-308.
Precaución: Estas citas no son 100% exactas.